Nuveen’s Celularity CELU Stock Holding History

Nuveen’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,937	Closed	-$124K	–	3222
2023 Q1	$124K	Sell	19,937 -260	-1%	-$2.09K	﹤0.01%	3037
2022 Q4	$260K	Buy	20,197 +1,510	+8%	+$27.8K	﹤0.01%	3016
2022 Q3	$432K	Buy	18,687 +8,584	+85%	+$260K	﹤0.01%	2988
2022 Q2	$343K	Buy	+10,103	New	+$821K	﹤0.01%	3081

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nuveen's CELU Position: Q2 2023 in Review

Nuveen sold out of Celularity (CELU) in Q2 2023, closing a stake of 19,937 shares — an estimated $124K sold.

Nuveen first reported a position in CELU in Q2 2022 and held it in 4 quarters. The position peaked at $432K in Q3 2022. 56 funds tracked by Wall St. Rank hold CELU as of Q2 2023.

Nuveen reported no remaining Celularity position as of Q2 2023 after selling out during the quarter.
Nuveen sold 19,937 Celularity shares in Q2 2023, an estimated $124K.
Nuveen first reported a position in Celularity in Q2 2022 and held it in 4 quarters.
Nuveen's Celularity position peaked at $432K in Q3 2022.
56 funds tracked by Wall St. Rank held Celularity as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.